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271possible protective eﬀects of lithium on behavioral and neu-
rochemical changes in socially isolated animals. Results
showed that experiencing 4-weeks of juvenile SIS provoked
depressive and anxiety-like behaviors that were associated
with hyper responsiveness of HPA axis, upregulation of
interleukin-1b, and nitric oxide (NO) overproduction in the
pre-frontal cortex and hippocampus. Administration of
lithium (10 mg/kg) signiﬁcantly attenuated the depressant
and anxiogenic eﬀects of SIS in behavioral tests. Lithium
also restored the negative eﬀects of SIS on cortical and hip-
pocampal interleukin-1b and NO as well as HPA axis dereg-
ulation. Unlike the neutralizing eﬀects of L-arginine (NO
precursor), administration of L-NAME (3 mg/kg) and
aminoguanidine (20 mg/kg) potentiated the positive eﬀects
of lithium on the behavioral and neurochemical proﬁle of
isolated mice. In conclusion, our results revealed that juve-
nile SIS-induced behavioral deﬁcits are associated with
abnormalities in HPA-immune function. Also, we suggest
that alleviating eﬀects of lithium on behavioral proﬁle
of isolated mice may be partly mediated by mitigating
the negative impact of NO on HPA-immune function.
 2015 IBRO. Published by Elsevier Ltd. All rights reserved.
Key words: juvenile social isolation stress, lithium, nitric
oxide, interlukine-1b, hypothalamic–pituitary–adrenal axis,
depressive-like behaviors.
INTRODUCTION
Depression, a condition accounting for enormous social
and ﬁnancial burden, is characterized by despair
behaviors, anhedonia, and depressed mood.
Adolescence is a pivotal period for brain development
accompanied with cortico-limbic maturation (Sisk and
Foster, 2004). Ample evidence indicated that experienc-
ing adversity namely by social stressors negatively alters
brain function and leads to the occurrence of psychiatric
disorders including depression and anxiety (Andersen
and Teicher, 2008; Romeo, 2010). Juvenile social isola-
tion stress (SIS) has been shown to produce behavioral
and neurochemical changes in social mammals reminis-
cent of various symptoms observed in depressed patients
(Fone and Porkess, 2008; Nestler and Hyman, 2010). A
large body of evidence reported that applying SIS to ani-
mals provoked behaviors relevant to depression and anx-
iety (Grippo et al., 2007; Fone and Porkess, 2008; Amiri
et al., 2015b).
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reported to exert antidepressant properties in preclinical
and clinical studies (Austin et al., 1991; Gray and
McEwen, 2013). In this context, advantageous eﬀects of
lithium on stress-induced psychiatric disorders have been
well documented in the literature (Kovacsics and Gould,
2010). Despite several mechanisms of action identiﬁed
for the therapeutic eﬀects of lithium, the exact mechanisms
through which lithium modulates the negative impacts of
stress remains elusive. Our previous studies showed that
the antidepressant eﬀect of lithium is partly associated with
nitric oxide (NO) modulation (Ghasemi et al., 2008, 2009).
It has been also demonstrated that lithium exerts anti-
inﬂammatory eﬀects and prevents interleukin-1b (IL-1b)
overproduction (Albayrak et al., 2013). On the other hand,
it has been proposed that lithium is able to modulate the
hypothalamic–pituitary–adrenal (HPA) axis dysregulation
in the variety of mood disorders (Bschor et al., 2002;
Boku et al., 2009). Evidence is accumulating that nitric
oxide synthase (NOS) overactivity, IL-1b overproduction,
and HPA-axis dysfunctions are involved in the pathophys-
iology of psychiatric disorders including depression and
anxiety (McEwen, 2005; Dantzer, 2009).
Several lines of research suggested that dysregulation
of the neuroimmune-endocrine system is one of the
fundamental mechanisms that underlie psychiatric
disorders (Pariante and Lightman, 2008). Evidence indi-
cates that experiencing social isolation during adolescence
correlates with HPA axis hyper responsiveness and inﬂu-
ences brain regions related to mood disorders such as
the pre-frontal cortex (PFC) and hippocampus (HIPP)
(Tsigos and Chrousos, 2002; Serra et al., 2005; Pariante
and Lightman, 2008; Hawkley et al., 2012; Gazdek-
Michalska et al., 2013a). Disruption of the HPA axis activity
after chronic stress exposuremight be a result of inﬂamma-
tory cytokines, including IL-1b and NO overproductions
(Gazdek-Michalska et al., 2013b). In addition, we have
recently shown that inducible NOS (iNOS) activity is asso-
ciated with co-occurrence of anxiety and depressive-like
behaviors following juvenile SIS (Amiri et al., 2015b).
Considering the protective properties of lithium in
modulating the negative eﬀects of stress and also the
putative role of glucocorticoids (GCs), NO, and IL-1b in
depression and anxiety development, we aimed to
investigate the eﬀect of lithium on the depressive and
anxiety-like behaviors in animals exposed to juvenile
SIS paradigm using behavioral tests. Although the
antidepressant and anxiolytic eﬀects of lithium has been
established by past studies, the possible eﬀect of this
drug on social stressors during adolescence, which is a
critical period in developing the brain of animals, has not
been illustrated yet. Also, our goal is to evaluate the
possible involvement of HPA axis, nitrergic system, and
IL-1b in mediating the protective eﬀect of lithium on
mood disorders in socially isolated mice.EXPERIMENTAL PROCEDURES
Animals
In the current study, we used male NMRI (Naval Medical
Research Institute) mice (Pasteur Institute, Tehran, Iran),weighing 10–14 g and on postnatal day (PND) 21–25.
Each experimental group consisted of 6–8 animals. The
animals were housed under standard conditions
(temperature: 23 ± 2 C, 12-h light–dark cycle, and free
access to food and water) for four weeks. Animals were
housed under two diﬀerent conditions, social condition
(SC), and isolated condition (IC). Socially conditioned
mice were housed in groups (six mice per cage) in
Plexiglas boxes (25  25  15 cm), while IC mice were
housed individually in Plexiglas boxes (24  17 
12 cm). Isolated conditioned mice were housed in a
separate room and had olfactory and visual contact.
The cages of IC mice were cleaned weekly by the same
experimenter to avoid minimum handling and social
contact. All procedures in our study were carried out in
accordance with the National Institutes of Health Guide
for the Care and Use of Laboratory Animals (NIH
Publications No. 80-23) revised 1996 or the UK Animals
(Scientiﬁc Procedures) Act 1986 and associated
guidelines, and we also adhered to institutional
guidelines for animal care and use (Department of
Pharmacology, School of Medicine, TUMS).Drugs
The following drugs were used in this study: lithium
chloride (Merck, Darmstadt, Germany), NG-nitro-L-
arginine methyl ester (L-NAME, non-selective NOS
inhibitor), aminoguanidine (AG, selective iNOS inhibitor),
and L-arginine (L-arg, NO precursor) (Sigma, St Louis,
MO, USA). All drugs were dissolved in sterile saline and
were administered in a volume of 5 ml/kg mouse weight.
All drugs were administered intraperitoneally (i.p.) to
animals. Doses and administration time of each drug
were chosen according to our pilot treatments and
previous published studies (Ghasemi et al., 2008; Amiri
et al., 2015b). The eﬃcacy and bioavailability of applied
drugs have been documented in the literature suggesting
the ability of them to pass through the blood–brain barrier
(Gyulai et al., 1991; Sakuma et al., 1992; Cockroft et al.,
1996; Tsuji et al., 2000).Forced swimming test (FST)
We used FST as a behavioral test in which the prolonged
immobility time presents the despair behavior reﬂecting
the depressive-like symptoms (Porsolt et al., 1977). Mice
were individually placed in an open glass cylinder (diam-
eter: 10 cm, height: 25 cm) containing 19 cm water (23
± 1 C). Mice were allowed to swim for 6 min, and the
immobility time was recorded during the last 4 min of
the test. Immobility behavior was considered when the
animal remained ﬂoating motionless in water and made
only those necessary movements to keep its head above
water.Splash test
In rodents, lack of motivation to engage in self-care can
be assessed by the splash test. In this test, grooming
behavior of mice, which can be considered as an
indirect measure of palatable solution intake was
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dorsal coat of animals while they were in their home
cages and mice were videotaped for 5 min. Duration of
grooming activity behavior including nose/face
grooming, head washing, and body grooming were
observed by an experimenter who was blind to the
treatment conditions (David et al., 2009; Detanico et al.,
2009).
Open-ﬁeld test (OFT)
The OFT was used to elucidate the eﬀects of SIS
and treatments on motor function and anxiety-like
behaviors (Kulesskaya and Voikar, 2014). The apparatus
consisted of a white opaque Plexiglas box measuring
(50 cm  50 cm  30 cm) which was dimly illuminated.
The ground of the box was separated into 16 equal
squares. Each mouse was placed gently on the central
zone (30 cm  30 cm) and its behaviors were recorded
by a camera for 5 min and were analyzed by Ethovision
software version 8 (Noldus, Netherlands). The surface
of the apparatus was cleaned with 70% ethanol after each
experiment. The distance moved (horizontal activity), the
number of rearings (vertical activity), and the time spent in
the central zone were evaluated.
Hole-board test (HBT)
The HBT was used to evaluate the anxiety-like behavior
of animals (Amiri et al., 2015b). The HBT consisted of a
white Plexiglas board (50 cm  50 cm) with 16 equidistant
holes (3 cm in diameter) and was positioned 50 cm above
the ﬂoor. Animals were placed in the center of the appa-
ratus and the number of head-dips was counted in a 5-
min period.
Nitrite assay
To determine the NO levels in the PFC and HIPP, we
measured the nitrite level as the NO end-product (Ding
et al., 2010; Kordjazy et al., 2015). The SC and IC animals
(without any acute stress induction) were decapitated
under mild anesthesia using diethyl ether, and then the
PFC or HIPP were dissected on the ice-cold surface
and immediately immersed in liquid nitrogen. Tissue
homogenates were prepared, and then the nitrite level
was measured by a colorimetric assay based on the
Griess reaction. First, 100 lL of samples were mixed with
100 lL Griess reagent. Following 10-min incubation at
room temperature, absorbance was measured at
540 nm in an automated plate reader. Concentration of
nitrite was determined by reference to a standard curve
of sodium nitrite (Sigma, USA) and normalized to the
weight of each sample.
Corticosterone assay
To evaluate the HPA axis activity in animals, we
measured basal (without any acute stress induction)
and post-stress (one hour after an acute stress which is
a 6-min forced swimming stress) levels of corticosterone
in serum using the previously described method in the
SC and IC animals (Veenema et al., 2003; Droste et al.,2008). Each animal was decapitated under mild anesthe-
sia using diethyl ether and the blood was collected. After
that, we centrifuged the obtained blood (3000g, 10 min, at
4 C) and the serum was collected; then the obtained
serum samples were stored at 20 C until the assay
day. Corticosterone levels were measured using a com-
mercial ELISA kit (Biospes, China).IL-1b gene expression
The SC and IC animals (without any acute stress
induction) were decapitated under mild anesthesia using
diethyl ether, and then the PFC or HIPP were dissected
on the ice-cold surface and immediately immersed in
liquid nitrogen. The tissue homogenates were prepared
and the IL-1b gene expression was evaluated using the
described method. Trizol (Invitrogen, Carlsbad,
California, USA) was used to isolate total RNA from
brain cells. Changes in mRNA levels of desired genes
were measured by qRT-PCR after reverse transcription
of 1 lg of RNA from each sample using PrimeScript RT
reagent kit (Takara Bio, Inc., Otsu, Japan). qRT-PCR
was performed on a light cycler instrument (Roche
Diagnostics, Mannheim, Germany) using SYBR Premix
Ex Taq technology (Takara Bio). Thermal cycling
conditions involved an initial activation step for 30 s at
95 C followed by 45 cycles including a denaturation
step for 5 s at 95 C and a combined annealing/
extension step for 20 s at 60 C. Melting curve analysis
was applied to validate whether all primers yielded
a single PCR product. The primers used for IL-1b is:
50-GAAATGCCACCTTTTGACAGTG-30(forward), 50-TG
GATGCTCTCATCAGGACAG-30(reverse). Hypoxanthine
phosphoribosyl transferase1 (hprt1) was ampliﬁed as
normalizer and the fold change in the expression of
each target mRNA relative to hprt1 was calculated on
the basis of 2DDct relative expression formulas.Experiment design and treatments
To determine the eﬀect of SIS on animal behaviors, after
4 weeks exposure to diﬀerent housing conditions (SC or
IC) animals were subjected to the behavioral tests, the
FST, splash test, OFT, and HBT. We also examined the
eﬀect of SIS on cortical and hippocampal nitrite and IL-
1b levels as well as serum corticosterone concentration.
Then, we evaluated the possible eﬀect of lithium (1, 5,
and 10 mg/kg, i.p., 30 min before behavioral tests) on
animals’ behavior in SC and IC groups. Also, the
possible eﬀect of lithium administration on the brain
nitrite and IL-1b levels and serum corticosterone
concentration was investigated in this part of the
experiment.
In the next step, we investigated whether the nitrergic
system mediates the eﬀects of lithium on depression and
anxiety induced by SIS. In this regard, we treated both SC
and IC mice with lithium and either of the following drugs:
L-NAME (3 mg/kg, i.p., 45 min before the tests), AG
(20 mg/kg, i.p., 45 min before the tests), and L-arg
(50 mg/kg, i.p., 45 min before the tests). After co-
administration of these drugs with lithium, ﬁrst, the
behavior of each mouse was assessed in open-ﬁeld or
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evaluated by FST or splash test (each mouse was used
in two behavioral tests). To exclude the possible eﬀect
of vehicle administration, SC and IC groups were
injected with 5 ml/kg sterile physiological saline. We also
measured the nitrite levels in PFC and HIPP of all
treated groups in order to further investigate the role of
nitrergic system in the observed eﬀects. Serum
corticosterone concentration was also measured in
experimental groups after acute stress induction.
Diﬀerent groups of SC and IC mice were used for nitrite
and corticosterone assays (these animals had not been
tested by behavioral tasks), in order to avoid the
possible eﬀects of behavioral experiments and
manipulations on these parameters. Each experimental
animal group consists of 6–8 in behavioral
assessments, and 3–8 in molecular evaluations.Statistical analysis
Comparison between the groups was analyzed using t-
test and a one-way and a two-way ANOVA followed by
multiple comparison tests in the SPSS package
software (version 21) and Graph-pad prism software
(version 6). P< 0.05 was considered statistically
signiﬁcant.RESULTS
Eﬀects of SIS on behavioral tests, brain IL-1b and
nitrite levels, and serum corticosterone
concentration
Applying SIS to mice induced depressive and anxiety-like
behaviors and also elevated animals’ locomotor activity.
Fig. 1a shows that the immobility time increased in the
socially isolated animals (IC) compared to the control
group (SC) in the FST (P< 0.001, Fig. 1a). In the
splash test, SIS signiﬁcantly decreased the grooming
activity time in IC mice when compared to SC mice
(P< 0.001, Fig. 1b). In the OFT, IC mice showed an
increase in both total distance moved (horizontal
activity) (P< 0.01, Fig. 1c) and number of rearings
(vertical activity) (P< 0.001, Fig. 1d) in comparison with
SC animals. Also, IC animals stayed for a shorter period
in the central zone compared to the SC group
(P< 0.01, Fig. 1e). In the HBT, SIS signiﬁcantly
reduced the number of head-dips of mice in comparison
with the SC group (P< 0.001, Fig. 1f).
In comparison with SC mice, t-test analysis showed
that IC mice contain higher levels of IL-1b in both PFC
(P< 0.05, Fig. 1g) and HIPP (P< 0.05, Fig. 1g). Also,
socially isolated animals have a higher nitrite level in
PFC (P< 0.001, Fig. 1h) and HIPP (P< 0.001, Fig. 1h)
compared to SC mice. Our data have shown that SIS
and drug manipulations (lithium) had no eﬀect on the
hprt1 gene expression (P> 0.05, data not shown).
Additionally, HPA axis response in IC mice after acute
stress was signiﬁcantly diﬀerent from post-stress SC
animals (P< 0.001, Fig. 1i). However, no signiﬁcant
diﬀerence was detected in the baseline corticosterone
levels between the unstressed IC and SC mice(P> 0.05, Fig. 1i). A two-way ANOVA analysis showed
signiﬁcant diﬀerence in the serum corticosterone
concentrations for the stress induction (F (1, 16)
= 31.44, P< 0.001), housing conditions (F (1, 16)
= 28.34, P< 0.001), and their interaction (F (1, 16)
= 11.13, P< 0.01).Lithium administration attenuated the depressant
and anxiogenic eﬀect of SIS
We intended to evaluate the possible antidepressant
eﬀect of lithium in socially isolated animals. Therefore,
behaviors of mice after administration of diﬀerent doses
of lithium (1, 5, and 10 mg/kg) were determined in SC
and IC groups (Fig. 2a, b). ANOVA analysis revealed
that there were signiﬁcant diﬀerences between lithium-
treated groups in FST (F (9, 70) = 5.33, P< 0.001,
Fig. 2a) and the splash test (F (9, 70) = 12.07,
P< 0.001, Fig. 2b). Tukey’s analysis showed that
administration of lithium (1, 5, and 10 mg/kg) had no
eﬀect on the immobility time in the FST (P> 0.05) or
the grooming activity time in the splash test (P> 0.05)
of SC animals. But, the result showed that
administration of lithium at doses 5 and 10 mg/kg
signiﬁcantly reversed the depressant eﬀect of SIS in IC
mice in FST (P< 0.05 and P< 0.01, respectively) and
splash test (P< 0.05 and P< 0.01, respectively).
However, administration of the lower dose of lithium
(1 mg/kg) did not alter either the immobility or grooming
times of IC mice in comparison with saline-treated IC
group (P> 0.05). Also, our results show that saline
treatment did not aﬀect behaviors of IC and SC mice in
the tests (P> 0.05).
After injection of diﬀerent doses of lithium, locomotor
activity and anxiety-like behaviors were determined in
SC and IC mice using behavioral tests including OFT
and HBT (Fig. 2c–f). Analysis demonstrated that there
were signiﬁcant diﬀerences between lithium-
administered groups in distance moved in OFT (F (9,
70) = 5.894, P< 0.001, Fig. 2c), number of rearings in
OFT (F (9, 70) = 10.15, P< 0.001, Fig. 2d), time spent
in the central zone in OFT (F (9, 50) = 5.156,
P< 0.001, Fig. 2e), and number of head-dips in HBT (F
(9, 70) = 7.762, P< 0.001, Fig. 2f). Tukey’s analysis
showed that lithium (1, 5, and 10 mg/kg) had no eﬀect
on SC mice in behavioral tests (P> 0.05); while,
administration of lithium induced anxiolytic eﬀects in IC
animals.
In the OFT, administration of lithium (1, 5, 10 mg/kg)
did not alter the number of rearings and total distance
moved of IC mice in comparison with saline-treated IC
group (P> 0.05). However, lithium (10 mg/kg)
administration (but not at the lower doses, 1 and 5 mg/kg)
improved the time spent in the central zone in IC
animals (P< 0.05). On the other hand, the results
showed that the number of head-dips in IC animals
treated with lithium (10 mg/kg, but 1 and 5 mg/kg) was
increased compared to the IC saline-injected group
(P< 0.01). Also, our results showed that saline
treatment did not aﬀect the behaviors of both IC and SC
mice in the OFT and HBT (P> 0.05).
Fig. 1. Eﬀect of housing condition on behaviors related to depression and anxiety and the neuroendocrine system. Eﬀect of diﬀerent housing
conditions, social condition (SC) and isolated condition (IC), on the immobility time in the FST (a), grooming activity time in the splash test (b), total
distance moved in the OFT (c), number of rearings in the OFT (d), time spent in the central zone in the OFT (e), number of head dips in the HBT (f),
fold changes in the IL-1b gene expression in the PFC and HIPP (g), cortical and hippocampal nitrite level (h), baseline state and post-stress (60 min
after an acute 6 min stress induction) serum corticosterone concentration (i). Values are expressed as the mean ± S.E.M and were analyzed using
t-test, a one-way and two-way ANOVA followed by Tukey’s post hoc test. *P< 0.05, **P< 0.01, ***P< 0.001, and ****P< 0.0001 compared with
the SC control group.
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levels, and serum corticosterone concentration
Eﬀects of lithium treatment on cortical and hippocampal
IL-1b and nitrite levels as well as post-stress serum
corticosterone concentration in SC and IC animals were
determined. A one-way ANOVA revealed signiﬁcant
eﬀect of lithium on IL-1b levels in the PFC (F (7, 16)
= 5.577, p< 0.01, Fig. 3a) and HIPP (F (7, 16)
= 3.913, p< 0.05, Fig. 3b). Data showed that lithium
(10 mg/kg, but not 1 mg/kg) injection considerably
reduced the cortical and hippocampal IL-1b levels in IC
mice when compared with the saline-treated IC group
(P< 0.05). None of these treatments altered the IL-1b
level of PFC and HIPP in SC mice (P> 0.05).
We also evaluated the eﬀect of lithium treatment on
the nitrite level in PFC (F (7, 56) = 14.34, p< 0.001,
Fig. 3c) and HIPP (F (7, 56) = 15.04, p< 0.001,
Fig. 3d) of SC and IC animals. Results also show that
lithium (10 mg/kg) injection reduced the nitrite levels
measured in PFC (P< 0.001) and HIPP (P< 0.01) of
IC mice when compared with IC control group. Lithium
at the dose of 1 mg/kg did not signiﬁcantly decrease thenitrite levels of PFC and HIPP in IC mice (P< 0.05).
Lithium administration did not aﬀect the nitrite levels of
PFC and HIPP in SC mice (P> 0.05).
In the next part, we assessed the eﬀects of lithium on
post-stress serum corticosterone level in SC and IC
animals (F (7, 32) = 6.510, p< 0.001, Fig. 3e). Our
data revealed that treatment with lithium (10 mg/kg, but
not 1 mg/kg) in IC mice signiﬁcantly decreased the
corticosterone concentration in serum comparing to
saline-treated IC animals (P< 0.01). However, lithium
(1 and 10 mg/kg) treatment did not change the post-
stress serum corticosterone level of SC animals
(P> 0.05).Nitrergic system mediates the antidepressant and
anxiolytic eﬀect of lithium in socially isolated animals
Fig. 4 shows the eﬀects of subeﬀective doses of NOS
inhibitors alone and in combination with lithium on the
behavioral tests of SC and IC animals. ANOVA analysis
showed that there were signiﬁcant diﬀerences between
all treated groups in FST (F (11, 84) = 5.722,
Fig. 2. Eﬀect of lithium chloride treatment on behaviors related to depression and anxiety in diﬀerent housing conditions. Eﬀects of lithium chloride
(1, 5, and 10 mg/kg) on the immobility time in the FST (a), grooming activity time in the splash test (b), total distance moved in the OFT (c), number
of rearings in the OFT (d), time spent in the central zone in the OFT (e), number of head dips in the HBT (f). Values are expressed as the mean ± S.
E.M and were analyzed using a one-way ANOVA followed by Tukey’s post hoc test. *P< 0.05, **P< 0.01, and ***P< 0.001 compared with the SC
control group. #P< 0.05 and ##P< 0.01 compared with the IC saline-treated group.
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P< 0.001, Fig. 4b). Tukey’s test showed that injection
of lithium chloride (1 mg/kg), L-NAME (3 mg/kg), and AG
(20 mg/kg) had no eﬀect on SC and IC mice either in
FST, or in splash test (P> 0.05).Co-administration of L-NAME (3 mg/kg) and lithium
(1 mg/kg) signiﬁcantly reversed the depressant eﬀect of
SIS on IC mice in FST (P< 0.01) and splash test
(P< 0.01); but this treatment did not alter the
behavioral tests of SC animals (P> 0.05). In addition,
Fig. 3. Eﬀect of lithium chloride treatment on neuroendocrine system in diﬀerent housing conditions. Eﬀects of lithium chloride (1 and 10 mg/kg) on
fold changes in the IL-1b gene expression in the PFC (a) and HIPP (b), Nitrite levels in the PFC (c) and HIPP (d), Post-stress (one hour after acute
6 min stress induction) serum corticosterone concentration (e). Values are expressed as the mean ± S.E.M and were analyzed using a one-way
ANOVA followed by Tukey’s post hoc test. *P< 0.05, **P< 0.01, and ***P< 0.001 compared with the SC control group. #P< 0.05, ##P< 0.01,
and ###P< 0.001 compared with the IC saline-treated group.
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Fig. 4. Eﬀects of lithium chloride and NOS inhibitors co-administration. Eﬀects of lithium chloride (Li) (1 mg/kg) and L-NAME (LNM) (3 mg/kg)/
aminoguanidine (AG) (20 mg/kg) co-administration on the immobility time in the FST (a), grooming activity time in the splash test (b), total distance
moved in the OFT (c), number of rearings in the OFT (d), time spent in the central zone in the OFT (e), number of head dips in the HBT (f). Values
are expressed as the mean ± S.E.M and were analyzed using a one-way ANOVA followed by Tukey’s post hoc test. *P< 0.05, **P< 0.01, and
***P< 0.001 compared with the SC control group. #P< 0.05, ##P< 0.01, and ###P< 0.001 compared with the IC saline-treated (S: saline-treated
groups).
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the antidepressant eﬀect of lithium (1 mg/kg) in IC
animals both in FST (P< 0.01) and splash test
(P< 0.01). However, lithium and AG co-injection did
not aﬀect the SC mice in FST and splash test (P> 0.05).
In addition, treatment with L-arg (50 mg/kg) abolished
the antidepressant eﬀect of lithium 10 mg/kg via
decreasing the immobility duration (F (7, 56) = 6.002,
P< 0.001, Fig. 5a) and enhancing the grooming activity
time (F (7, 56) = 13.07, P< 0.001, Fig. 5b) of IC
animals when compared to IC saline-treated group. So,
there were signiﬁcant diﬀerences between lithium
(10 mg/kg) and lithium- (10 mg/kg) + L-arg (50 mg/kg)
administered groups in both the FST (P< 0.05) and
splash test (P< 0.05). However, lithium and L-arg
injections did not aﬀect the SC mice behaviors either
alone or in combination (P> 0.05).
In order to evaluate the possible role of nitrergic
system in mediating the anxiolytic eﬀect of lithium, the
subeﬀective doses of NO agents were administered
alone and in combination with lithium to SC and IC
animals. Analysis showed that there were signiﬁcant
diﬀerences between all treated groups in the distance
moved in OFT (F (11, 84) = 6.312, P< 0.001, Fig. 4c),
number of rearings in OFT (F (11, 84) = 14.21,
P< 0.001, Fig. 4d), time spent in the central zone in
OFT (F (11, 60) = 4.840, P< 0.001, Fig. 4e), and
number of head-dips in HBT (F (11, 84) = 7.069,
P< 0.001, Fig. 4f). Tukey’s analysis showed that
injection of lithium chloride (1 mg/kg), L-NAME (3 mg/
kg), and AG (20 mg/kg) did not alter the SC and IC
animals’ behaviors in OFT or HBT (P> 0.05).
Data have shown that co-administration of L-NAME
(3 mg/kg) or AG (20 mg/kg) with lithium (1 mg/kg) did
not change the number of rearings and total distance
moved of IC animals in the OFT (P> 0.05). But L-
NAME (3 mg/kg) and lithium (1 mg/kg) co-treatment
(P< 0.05) as well as AG (20 mg/kg) and lithium (1 mg/
kg) co-injection (P< 0.01) signiﬁcantly enhanced the
time spent in the central zone of IC mice when
compared to IC saline-treated group. In addition,
administration of L-NAME (3 mg/kg) and AG (20 mg/kg)
signiﬁcantly augmented the anxiolytic eﬀect of lithium
(1 mg/kg) in IC animals in HBT (P< 0.01 and
P< 0.001, respectively). Analysis showed that none of
the above-mentioned treatments changed the behaviors
of the SC group in the OFT and HBT (P> 0.05).
Results showed that L-arg (50 mg/kg) and lithium
(10 mg/kg) co-treatment did not change the number of
rearings and total distance moved of IC animals in the
OFT (P> 0.05, Fig. 5c, d). However, treatment with L-
arg (50 mg/kg) attenuated the anxiolytic eﬀect of lithium
10 mg/kg in IC mice by decreasing the time spent in the
central zone in OFT (F (7, 40) = 6.371, P< 0.001,
Fig. 5e) and head-searching activity in HBT (F (7, 56)
= 10.89, P< 0.001, Fig. 5f). There were signiﬁcant
diﬀerences between lithium (10 mg/kg) and lithium
(10 mg/kg) + L-arg (50 mg/kg) administered groups in
the time in the central zone of OFT (P< 0.05) and
number of head dips of HBT (P< 0.01). Concurrent
lithium and L-arg injection did not change the behaviorsof SC mice in the OFT and HBT either alone or in
combination (P> 0.05).
Pre-frontal cortex and hippocampus nitrite levels in
diﬀerent housing conditions and treatments
The eﬀects of lithium and NO agent administrations on
cortical and hippocampal nitrite levels in SC and IC
animals were determined (Table 1). A one-way ANOVA
revealed signiﬁcant eﬀect of treatments on the nitrite
measured in PFC (F (9, 70) = 12.59, P< 0.001,
Table 1) and HIPP (F (9, 70) = 8.202, P< 0.001,
Table 1). Data showed that lithium (10 mg/kg, but not
1 mg/kg) injection considerably reduced the cortical
(P< 0.001) and hippocampal (P< 0.01) nitrite levels in
IC mice when compared with IC control group. We
assessed the eﬀects of NOS inhibitors/NO precursor co-
administration with lithium on cortical and hippocampal
nitrite levels. Our data revealed that co-administration of
lithium (1 mg/kg) with L-NAME (3 mg/kg) or AG (20 mg/
kg) in IC mice signiﬁcantly decreased the nitrite levels in
PFC (P< 0.01 and P< 0.001) and HIPP (P< 0.01
and P< 0.01) comparing to IC animals. Table 1 also
shows that L-arg (50 mg/kg) injection abolished the
eﬀect of lithium (10 mg/kg) on nitrite levels reduction in
the PFC (P< 0.001) and HIPP (P< 0.001). On the
other hand, subeﬀective doses of NOS inhibitors and
NO precursor did not change the nitrite levels in PFC
and HIPP when they were applied singly (P> 0.05).
Post-stress corticosterone assay in diﬀerent housing
conditions and treatments
The eﬀects of drugs treatment on post-stress (one our
after an acute 6 min forced swimming stress) serum
corticosterone concentration in SC and IC animals are
shown in Table 1. A one-way ANOVA revealed
signiﬁcant eﬀect of treatments on the serum
corticosterone level (F (9, 40) = 4.081, P< 0.001,
Table 1). Tukey’s analyses revealed that lithium (10 mg/
kg, but not 1 mg/kg) injection signiﬁcantly reduced the
corticosterone level in IC mice when compared with IC
control group (P< 0.01). Co-administration of lithium
(1 mg/kg) with L-NAME (3 mg/kg) or AG (20 mg/kg) in
stressed mice signiﬁcantly decreased the serum
corticosterone level after acute stress in IC animals
(P< 0.05 and P< 0.01). We also showed that L-arg
(50 mg/kg) injection reversed the normalizing eﬀect of
lithium (10 mg/kg) on corticosterone level (P< 0.05).
None of the applied doses of NOS inhibitors and NO
precursor changed the serum corticosterone
concentration in IC animals (P> 0.05).
DISCUSSION
Results of the current study showed that experiencing 4-
weeks of SIS in the adolescence provoked depressive
and anxiety-like behaviors in male mice. These
behavioral changes were associated with upregulation
of IL-1b, NO overproduction, and HPA axis
dysregulation in the socially isolated animals. Our
results also revealed that administration of lithium not
Fig. 5. Eﬀects of lithium chloride and NO precursor co-administration. Eﬀects of lithium chloride (Li) (10 mg/kg) and L-arginine (L-arg) (50 mg/kg) co-
administration on the immobility time in the FST (a), grooming activity time in the splash test (b), total distance moved in the OFT (c), number of
rearings in the OFT (d), time spent in the central zone in the OFT (e), number of head dips in the HBT (f). Values are expressed as the mean ± S.E.
M and were analyzed using a one-way ANOVA followed by Tukey’s post hoc test. *P< 0.05, **P< 0.01, and ***P< 0.001 compared with the SC
control group. #P< 0.05 and ##P< 0.01 compared with the IC lithium- (10 mg/kg) treated group (Li group) (S: saline-treated groups).
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Table 1. Eﬀect of lithium chloride and NOS inhibitors/NO precursor co-treatments on PFC and HIPP nitrite level and post-stress serum corticosterone
concentration
Groups Nitrite (nM/mg protein) Serum Corticosterone (ng/ml)
PFC HIPP
Social condition (SC) 30.4 ± 6.4 75.4 ± 10 23 ± 4.3
Isolated condition (IC) 52.4 ± 11*** 127 ± 13*** 35.2 ± 3.6**
+Lithium chloride (1 mg/kg) 44.8 ± 12.9** 113.1 ± 28** 31 ± 8.8
+Lithium chloride (10 mg/kg) 34.5 ± 6.6### 93 ± 23## 24.4 ± 4.6##
+L-NAME (3 mg/kg) 51.7 ± 5.2*** 112 ± 17** 33.4 ± 6.1*
+Aminoguanidine (20 mg/kg) 50.1 ± 4.8*** 119 ± 14** 32.7 ± 5.4*
+L-arginine (50 mg/kg) 56.2 ± 3.6*** 139 ± 33*** 35.8 ± 6.3**
+Lithium chloride (1 mg/kg) + L-NAME (3 mg/kg) 39.2 ± 4.3## 94 ± 11## 29 ± 2.5#
+Lithium chloride (1 mg/kg) + Aminoguanidine (20 mg/kg) 32.7 ± 3### 89 ± 21## 25.4 ± 2.8##
+Lithium (10 mg/kg) + L-arginine (50 mg/kg) 49.8 ± 9.3*** 121 ± 9*** 33.7 ± 4*
Eﬀects of lithium chloride (1 mg/kg) and NOS antagonists including L-NAME (3 mg/kg), aminoguanidine (20 mg/kg) co-administrations as well as lithium chloride (10 mg/kg)
and L-arginine (50 mg/kg) co-administration on the cortical and hippocampal nitrite level and post-stress (one hour after an acute 6 min stress induction) serum corticosterone
concentration in the IC animals. Values are expressed as the mean ± S.D. and were analyzed using a one-way ANOVA followed by Tukey’s post hoc test.
* P< 0.05 compared with the SC control group.
** P< 0.01 compared with the SC control group.
*** P< 0.001 compared with the SC control group.
# P< 0.05 compared with the IC control group.
## P< 0.01 compared with the IC control group.
### P< 0.001 compared with the IC control group.
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SIS, but also attenuated the expression of IL-1b and NO
overproduction (mostly by iNOS inhibition) in the PFC
and HIPP. In addition, we suggest that antidepressant
and anxiolytic eﬀects of lithium may be associated with
moderating the negative eﬀects of IL-1b and iNOS on
the HPA axis function.
Social isolation stress induces depressive and
anxiety-like behaviors through HPA axis
dysregulation and IL-1b/NO overproduction
Experiencing juvenile SIS has been extensively
reported to negatively induce long-lasting behavioral,
neuroendocrinological, and immunological changes in
animals (Sandi and Haller, 2015). Using FST as a valid
behavioral test to evaluate the passive behaviors in
rodents in response to acute stress, our results showed
that exposing juvenile mice to 4-weeks of SIS is able to
increase immobility time in the FST reﬂecting the behav-
ioral despair in IC mice (Cryan and Holmes, 2005). Also,
IC mice exhibited a signiﬁcant decrease in grooming
activity time in the splash test indicating that SIS evoked
the motivational and self-care diﬃculties in these animals.
Although there are pieces of evidence that has reported
SIS do not induce depressive-like behaviors in the FST
(Hall et al., 1998; Pisu et al., 2011), there is consensus
agreement that SIS, namely during adolescence, is able
to provoke depressive-like behaviors not only in the FST
but also in other behavioral measures of depression
(Grippo et al., 2008; Berry et al., 2012; Evans et al.,
2012; Chang et al., 2015). In addition, passive behaviors
of stressed animals in our experiments were not related to
the changes of locomotor activity. Although the FST is
quite tried and trusted, false results might be obtained
with sedation and sickness conditions; therefore, we mea-
sured the behaviors in OFT relevant to locomotion in
order to validate the FST results. This is in agreement
with previous studies that have demonstrated SISincreases the locomotion in rodents. Our results showed
that IC mice exhibit an increase in both vertical and hori-
zontal activity in the OFT. In consistence with previous
investigations on the anxiogenic eﬀects of SIS, our results
revealed that IC mice show anxiety-like behaviors in the
OFT (decrease in the time spent in the central zone)
and HBT (decrease in number of head-dips) (Fone and
Porkess, 2008; Amiri et al., 2015a). We recently demon-
strated that juvenile SIS not only accounts for shaping
the depressive and anxiety-like behaviors in mice, but
also is an animal model for investigation the co-
occurrence of anxiety and depressive-like behaviors
(Haj-Mirzaian et al., 2015; Amiri et al., 2015b).
Ample evidence indicates the contribution of HPA axis
in the pathophysiology of depression. In this regard, both
clinical and preclinical studies have shown that
depression correlates with elevated serum levels of GCs
and the inability of the HPA axis to manage the
response to acute stress (Lupien et al., 2009). A compre-
hensive review by Hawkley and colleagues has investi-
gated the impact of SIS on HPA axis activity and
suggests that eﬀects of SIS on HPA axis depend on a
variety of factors such as age, species and duration of
stress. Furthermore, they concluded that SIS enhances
the responsiveness of HPA axis to acute stressors (but
not in the basal state) and also, the exaggerated response
of HPA axis is accompanied by inﬂammatory responses
in mammals (Hawkley et al., 2012). In response to an
acute swim stress, our results showed that while there
was no signiﬁcant diﬀerence in basal corticosterone levels
between IC and SC mice, IC mice had higher concentra-
tions of corticosterone than their counterparts 60 min after
acute stress induction. This result indicates the failure of
the HPA axis to restore the corticosterone levels to basal
state following exposure to acute stress in socially isolated
animals. Also, previous studies on the responsiveness
of HPA axis in socially isolated rats have shown that
these animals had a greater HPA axis activity following
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releasing factor (CRF) indicating the impaired negative
feedback in the animals (Serra et al., 2005, 2007).
On the other hand, emerging lines of evidence
indicates the involvement of inﬂammatory factors in the
pathophysiology of depression (Maes et al., 2009). Role
of IL-1b in modulating the depressive-like behaviors has
been well documented in the literature (Goshen et al.,
2008). There is a bidirectional relationship between
inﬂammatory factors such as IL-1b and HPA axis activity.
In this regard, it has been shown that chronic exposure to
GCs results in activation of IL-1b and similarly, IL-1b is
able to activate the HPA axis responses (Goshen et al.,
2008; Goshen and Yirmiya, 2009; Frank et al., 2014). In
agreement with previous research on socially isolated ani-
mals, our results demonstrated the upregulation of IL-1b
gene in both HIPP and PFC of IC mice.
Also, results of our laboratory and others suggest that
SIS activates the NOS activity in HIPP and PFC that
results in increased nitrite levels in these regions of the
brain. We recently showed that iNOS plays a role in
mediating the co-occurrence of anxiety and depressive-
like behaviors in socially isolated mice (Zlatkovic´ et al.,
2014; Amiri et al., 2015b). Recent studies also have
reported the involvement of iNOS in the modulation of
depressive and anxiety-like behaviors in animal models
of depression (Montezuma et al., 2012; Peng et al.,
2012; Tomaz et al., 2014). Considering the immune-
HPA axis communications, recent investigations suggest
that stimulatory eﬀect of IL-1b on HPA axis activity may
be mediated by the NO generated by iNOS in the PFC
and HIPP (Gadek-Michalska and Bugajski, 2005;
Gazdek-Michalska et al., 2012, 2013b). To support this, it
has been demonstrated that application of NOS inhibitors
attenuated IL-1b-induced CRH release and HPA axis
responses (Gazdek-Michalska et al., 2013b).
Altogether, juvenile SIS caused HPA axis
abnormalities, overexpression of IL-1b and elevated
levels of NO in the HIPP and PFC that have already
been reported to participate in the development of
depression and anxiety-like behaviors.Lithium attenuated the depressant and anxiogenic
eﬀects of juvenile SIS by targeting the negative
impact of IL-1b/NO on HPA axis function
Evidence is accumulating that lithium is not only
considered as an eﬀective treatment for mood disorders,
but is also able to ameliorate the detrimental outcomes
of stress on the brain through diﬀerent pathways (Gray
and McEwen, 2013; Bschor, 2014). Apart from therapeu-
tic eﬀects of lithium that have been attributed to regulation
of GSK-3b and N-methyl-D-aspartate (NMDA) receptors,
recent evidence indicates the anti-inﬂammatory eﬀects of
lithium (Ghasemi and Dehpour, 2011; Beurel and Jope,
2014; Nassar and Azab, 2014). Results of our laboratory
have previously demonstrated that antidepressant-like
eﬀects of both acute and chronic lithium are associated
with NO. In this study, our results showed that acute
administration of lithium (5 and 10 mg/kg, but not 1 mg/
kg) attenuated the negative behavioral eﬀects of SIS onIC (but not SC) mice. These results were in agreement
with similar studies which reported that these doses of
lithium do not cause antidepressant and anxiolytic eﬀects
in non-stressed animals (Ghasemi et al., 2008; Gould
et al., 2008). In consistence with previous reports, we also
demonstrated that lithium (10 mg/kg) succeeded to miti-
gate overexpression of IL-1b and NO overproduction in
PFC and HIPP, as well as moderating the HPA axis hyper
responsiveness to acute stress (Boku et al., 2009;
Nahman et al., 2012; Nassar and Azab, 2014). As men-
tioned above, there is evidence suggesting the interac-
tions between inﬂammatory factors and HPA axis. In
this work, we showed that nitrergic system (mainly iNOS)
contributes to positive eﬀects of low-dose lithium against
detrimental inﬂuences of SIS on animals. In this context,
results showed that administration of subeﬀective dose
of lithium along with subeﬀective doses of L-NAME or
AG reversed the depressant and anxiogenic eﬀects of
SIS in IC mice. Same treatments with lithium and NOS
inhibitors led to a decrease in NO overproduction in HIPP
and PFC and, attenuation of HPA axis hyper responsive-
ness. In addition, lithium failed to produce protective
eﬀects in IC mice when animals were pretreated with
L-arg indicating that NO (namely iNOS) plays a part in
regulatory eﬀects of lithium on HPA axis, inﬂammatory
and behavioral proﬁle of isolated mice.
Nitric oxide plays an important regulatory role in
mediating various (patho) physiological processes in the
brain. Numbers of studies have indicated that NOS
inhibition results in antidepressant-like eﬀects in a
variety of animal models of depression (Wang et al.,
2008; Mutlu et al., 2009). These reports have speculated
that inhibiting NOS in the brain may play enhancing role in
the antidepressant eﬀect of many compounds (Harkin
et al., 1999; Ghasemi et al., 2008; Krass et al., 2011).
Some reports have focused on the involvement of nNOS
in the pathophysiology of depression (Joca and
Guimara˜es, 2006); nNOS is a more abundant isoenzyme
in the brain in physiological and normal conditions. How-
ever, it has been reported that over-expression of iNOS
is mostly observed during conditions such as inﬂamma-
tion and chronic stress (Olivenza et al., 2000; Harvey
et al., 2004). Under chronic stressful conditions such as
SIS, prolonged exposure to GCs results in priming the
innate immune system in the brain mostly glial cells.
Microglia, the resident macrophages in the brain, is sus-
ceptible to GCs-induced metabolic changes and initiates
the inﬂammatory responses through producing inﬂamma-
tory mediators including IL-1b and iNOS (Picard et al.,
2014; Re´us et al., 2015). Inducible NOS not only medi-
ates several inﬂammatory pathways in psychiatric and
neurodegenerative disorders, but is also involved in
HPA axis regulations and mediates the eﬀects of IL-1b
on HPA axis activity (Rettori et al., 2009; Gazdek-
Michalska et al., 2013b; Chen et al., 2015). On the other
hand, it has been shown that elevated level of NO has a
negative inﬂuence on mitochondrial function (Moncada
and Erusalimsky, 2002; Doherty, 2011). In order to
explain the possible underlying mechanisms account for
the eﬀects of lithium, our (un) published ﬁndings revealed
that juvenile SIS deleteriously change the energy and
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bition of iNOS not only reversed the mitochondrial dys-
function and energy deﬁcits but also improved the
behavioral proﬁle of isolated mice relevant to anxiety
and depression (Amiri et al., 2015a). Also, lithium has
been well demonstrated to improve the performance of
mitochondria and antioxidant system under pathological
conditions (Chiu et al., 2015; Silachev et al., 2015;
Valvassori et al., 2015). Therefore, it is possible that
lithium exerts its eﬀects by reducing the mitochondrial
dysfunction and inﬂammatory responses. Altogether, our
data suggests that anxiolytic and antidepressant-like
eﬀects of lithium are partly mediated by NO and its atten-
uating eﬀects on immune-HPA axis function.
On the other hand, in our pilot studies we found that
when lithium chloride was injected intraperitoneally at
the doses of 1 and 10 mg/kg in SC and IC animals, the
serum concentration of Li reached to 0.0345 and
0.281 mM, respectively (30 min after injection). Our
results showed that the applied doses of lithium in this
study provided therapeutical concentrations of lithium in
serum, therefore, it seemed not necessary to investigate
the eﬀects of other doses in acute or chronic manner.
Also, administration of chronic lithium to IC mice was
accompanied by some problems in the study design
because there was a concern that any handling or
contact with isolated animals for daily oral gavage or
intraperitoneal injections could signiﬁcantly antagonize
the eﬀects of SIS. The only way to treat animals with
lithium was to dissolve the lithium dose in their drinking
water. Considering the diﬀerent weight gain during the
isolation period (4 weeks), it was not possible to treat
the mice with the exact dose of lithium because of the
variations in mice weight gain. Also, we considered the
possible eﬀects of lithium on the developing brain. Since
adolescence reﬂects the age 8–18 years in humans,
administration of lithium to juvenile mice at these ages
is not clinically relevant. Although we could treat the
animals after termination of the isolation process, we
rather treated mice with acute lithium in order to
investigate the mechanism through which lithium may
exert its eﬀects.
CONCLUSION
In conclusion, results of this study revealed that lithium
has a protective role against depressant and anxiogenic
eﬀects of juvenile SIS. We showed that antidepressant
and anxiogenic-like eﬀects of lithium are partially
mediated through HPA axis, nitrergic system, and IL-1b.
Lithium mitigated the HPA axis hyper responsiveness in
socially stressed animals through declining the IL-1b
over expression and suppressing NO overproduction
(mostly by iNOS inhibition) in the PFC and HIPP of mice.
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